Ratings by H.C. Wainwright (Ed Acre)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2024 | Terns Pharmaceuticals | TERN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Terns Pharmaceuticals | TERN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/13/2023 | Chinook Therapeutics | KDNY | Downgrade | Neutral (Buy) |
37.98 (40.39) |
6.35% | Details | |
| 5/10/2023 | Chinook Therapeutics | KDNY | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Terns Pharmaceuticals | TERN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/29/2023 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Chinook Therapeutics | KDNY | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2022 | Terns Pharmaceuticals | TERN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Chinook Therapeutics | KDNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Terns Pharmaceuticals | TERN | New Coverage | Neutral (N/A) |
5.27 (4.64) |
-11.95% | Details | |
| 8/15/2022 | Chinook Therapeutics | KDNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2022 | Nabriva Therapeutics AG | NBRV | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/25/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 2/1/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 8/11/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2020 | Chinook Therapeutics | KDNY | New Coverage | Buy (N/A) |
14.43 (40.39) |
179.9% | Details | |
| 11/6/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2020 | Avenue Therapeutics | ATXI | Downgrade | Neutral (Buy) |
11.04 (0.12) |
-98.91% | Details | |
| 8/10/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Avenue Therapeutics | ATXI | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2020 | Nabriva Therapeutics AG | NBRV | Downgrade | Neutral (Buy) |
0.54 (1.42) |
162.96% | Details | |
| 2/13/2020 | Avenue Therapeutics | ATXI | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2019 | Nabriva Therapeutics AG | NBRV | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2019 | Nabriva Therapeutics AG | NBRV | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2019 | Avenue Therapeutics | ATXI | Maintain | Buy (N/A) |
|
Details |
